MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$2,516,000
EPS
-$0.07
Unit: Dollar

Income Statement
2026-04-30
2026-01-31
2025-10-31
2025-07-31
Revenue
NaN NaN NaN 0
Research and development expenses (including non-cash stock-based compensation expenses of 286, 417, 624 and 814, respectively)
1,258,000 1,102,000 1,505,500* 1,055,000
General and administrative expenses (including non-cash stock-based compensation expenses of 379, 571, 837 and 1,229, respectively)
1,389,000 1,614,000 2,037,000* 1,381,000
Total operating expenses
2,647,000 2,716,000 3,542,500 2,436,000
Loss from operations
-2,647,000 -2,716,000 -3,542,500* -2,436,000
Interest income
111,000 131,000 154,000* 156,000
Net loss
-2,536,000 -2,585,000 -3,388,500* -2,280,000
Less net loss attributable to noncontrolling interest
-20,000 -20,000 -33,500* -22,000
Net loss attributable to common shareholders
-2,516,000 -2,565,000 -3,355,000 -2,258,000
Basic EPS
-0.07 -0.08 0.052 -0.07
Diluted EPS
-0.07 -0.08 0.052 -0.07
Basic Average Shares
33,593,000 33,240,000 -64,580,638 32,476,000
Diluted Average Shares
33,593,000 33,240,000 -64,580,638 32,476,000
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net lossattributable to common...-$2,516,000 (9.82%↑ Y/Y)Less net lossattributable to...-$20,000 (13.04%↑ Y/Y)Net loss-$2,536,000 (9.85%↑ Y/Y)Interest income$111,000 (-41.58%↓ Y/Y)Loss from operations-$2,647,000 (11.85%↑ Y/Y)Total operatingexpenses$2,647,000 (-11.85%↓ Y/Y)General andadministrative expenses...$1,389,000 (-17.37%↓ Y/Y)Research and developmentexpenses (including...$1,258,000 (-4.84%↓ Y/Y)

Anixa Biosciences Inc (ANIX)

Anixa Biosciences Inc (ANIX)